KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin.

Emil A Tanghetti, Joshua A Zeichner, Michael Gold, Neil Sadick, Fran E Cook-Bolden, Leon H Kircik, Linda Stein Gold, Jonathan Weiss, Stephen K Tyring, James Q Del Rosso, Eric Guenin

J Dermatolog Treat 34(1) 2147391

PMID36382987
PMCID-
DOI10.1080/09546634.2022.2147391
发表日期2022-11-16
摘要

摘要

BACKGROUND: Excessive sebum production is a factor in acne development. Tazarotene 0.045% lotion has demonstrated reductions in acne lesions and acne-induced sequelae. OBJECTIVE: Evaluate efficacy, changes in skin oiliness, and safety with tazarotene 0.045% lotion in participants with moderate-to-severe acne and oily skin. METHODS: In two phase 3, double-blind, 12-week studies (NCT03168321; NCT03168334), participants aged ≥ 9 years with moderate-to-severe acne were randomized 1:1 to once-daily tazarotene 0.045% lotion or vehicle lotion (N = 1614). This pooled, post hoc analysis included only participants self-categorized with oily skin at baseline on the Acne-Specific Quality of Life questionnaire item 19 (scores: 0 [extremely oily] to 6 [not at all oily]). Inflammatory/noninflammatory lesion counts, treatment success, skin oiliness, treatment-emergent adverse events (TEAEs), and cutaneous safety/tolerability were evaluated. RESULTS: In all participants with oily skin (n = 793), tazarotene provided greater reductions in inflammatory/noninflammatory lesions (p < 0.001, both) and greater treatment success rates versus vehicle (p < 0.01) at week 12. Over two-thirds of polymeric lotion-treated participants had subjective skin oiliness reductions by week 12, with around a third reporting 'low/not' oily skin. Tazarotene TEAE rates were similar to the overall population. CONCLUSIONS: Once-daily treatment with tazarotene 0.045% polymeric emulsion lotion may help improve patient-perceived skin oiliness in those with moderate-to-severe acne.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。